Iron deficiency anaemia (IDA) affects nearly half of pregnant women in India. Left untreated, it raises the risk of preterm birth, low birth weight, and maternal complications.
Treatment ladder
- Mild IDA (Hb 10–11 g/dL): Oral iron — ferrous sulphate, fumarate, or polysaccharide-iron complexes; co-administered with vitamin C for absorption.
- Moderate IDA (Hb 8–10 g/dL): Higher-dose oral iron, sometimes switched to parenteral if intolerance or poor response.
- Severe IDA (Hb <8 g/dL): IV Iron Sucrose or Ferric Carboxymaltose; faster correction with fewer doses.
Why formulation matters
Not all iron supplements are tolerated equally. Patient compliance often drops due to GI side effects. Modern preparations like ferrous bis-glycinate offer comparable absorption with better tolerability.
Explore our complete iron and haematinic range.
Tags:Iron TherapyAntenatalAnaemia
